| Health / Medical Topics |
Robatumumab
A recombinant, fully human monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Anti-IGF-1R fully human monoclonal antibody SCH 717454 binds to membrane-bound IGF-1R, preventing binding of the ligand IGF-1 and the subsequent triggering of the PI3K/Akt signaling pathway; downregulation of this survival pathway may result in the induction of apoptosis and decreased cellular proliferation. The activation of IGF-1R, a tyrosine kinase and a member of the insulin receptor family, stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis; IGF-1R signaling has been highly implicated in tumorigenesis and metastasis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of cancer. It blocks certain enzymes that are needed for cell growth. This may…
A substance that is being studied in the treatment of anemia in patients who are receiving chemotherapy. It is a form of…
A methanesulfonate salt form, a staurosporine analog that inhibits protein kinase C and induces apoptosis.
A substance that is being studied in the treatment of cancer. It may prevent cancer cells from dividing. It belongs to the…
A synthetic retinoid with differentiation inducing and potential antineoplastic activities. Like other retinoic acid agents, Ro 16-9100 binds to and activates retinoic…
Human RNR1 wild-type allele is located in the vicinity of 13p12 and its length is unknown. This allele, which encodes RNA, ribosomal…
